Predictors and benefits of multiagent chemotherapy for pancreatic adenocarcinoma: Timing matters.
Valdera FA, O'Shea AE, Smolinsky TR, Carpenter EL, Adams AA, McCarthy PM, Tiwari A, Chick RC, Kemp-Bohan PM, Van Decar S, Thomas KK, Bader JO, Peoples GE, Clifton GT, Stojadinovic A, Nelson DW, Vreeland TJ.
Valdera FA, et al. Among authors: adams aa.
J Surg Oncol. 2024 Feb;129(2):244-253. doi: 10.1002/jso.27466. Epub 2023 Oct 6.
J Surg Oncol. 2024.
PMID: 37800378